EGFR and colorectal carcinoma: Sensitivity was correlated with hypoploidy (Fisher's exact test P=0.003), and with CNV gain of MYC and AURKA (Fig. 9e), suggesting that tumours sensitive to EGFR blockade might rely on the MYC-AURKA axis, a relevant pathway in CRC (ref. 57).